RICHLAND, WA--(Marketwired - Nov 15, 2013) - IsoRay, Inc. (NYSE MKT: ISR) (NYSE Amex: ISR) (http://www.isoray.com/), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of cancers of the brain, lung, head and neck, prostate and gynecological, announced its financial results for the quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
